Total assets of Moderna Inc. from 2016 to 2025 (in million U.S. dollars)

Moderna total assets 2016-2025

Last update: Jul 22, 2026

Regions: Worldwide, United States of America

Survey time period: From 01/01/2016 to 31/12/2025

In 2025, Moderna's total assets stood at around billion U.S. dollars, another drop compared to the preceding years. Moderna became widely known as one of the two companies whose COVID-19 vaccines were approved in late 2020.

Related insights

Total assets of Moderna from 2021 to 2025 (in billion U.S. dollars)
Moderna Inc.'s net income from 2016 to 2025 (in million U.S. dollars)
Revenue of Moderna from 2021 to 2025 (in billion U.S. dollars)
Total assets of Humana from 2021 to 2025 (in billion U.S. dollars)
Total assets of Medicinova from 2021 to 2025 (in million U.S. dollars)
Liabilities of Moderna from 2021 to 2025 (in billion U.S. dollars)
Total assets of Vanda Pharmaceuticals from 2021 to 2025 (in million U.S. dollars)
Total assets of Molina Healthcare from 2021 to 2025 (in billion U.S. dollars)
Total assets of Novavax from 2021 to 2025 (in billion U.S. dollars)
Moderna - Statistics & Facts
Total assets of Monte Rosa Therapeutics from 2021 to 2025 (in million U.S. dollars)
Total assets of Bioatla from 2021 to 2025 (in million U.S. dollars)
Total assets of Sana Biotechnology from 2021 to 2025 (in million U.S. dollars)
Total assets of BioNTech SE from 2017 to 2025 (in million euros)
Total assets of Immunovant, Inc. from 2021 to 2025 (in million U.S. dollars)
Total assets of Armata Pharmaceuticals from 2021 to 2025 (in million U.S. dollars)
Total assets of Matinas Biopharma Holdings from 2021 to 2025 (in million U.S. dollars)
Total assets of Allena Pharmaceuticals from 2017 to 2021 (in million U.S. dollars)
Total assets of Cigna from 2021 to 2025 (in billion U.S. dollars)
Total assets of Reviva Pharmaceuticals Holdings, Inc. from 2021 to 2025 (in million U.S. dollars)
Total assets of Enanta Pharmaceuticals from 2021 to 2025 (in million U.S. dollars)
Total assets of Natera from 2021 to 2025 (in billion U.S. dollars)
Total assets of Anika Therapeutics from 2021 to 2025 (in million U.S. dollars)
Total assets of Mannatech from 2021 to 2025 (in million U.S. dollars)
Total assets of Biomerica from 2021 to 2025 (in million U.S. dollars)
Total assets of MetaVia Inc. from 2021 to 2025 (in million U.S. dollars)
Total assets of Theriva Biologics, Inc. from 2021 to 2025 (in million U.S. dollars)
Market capitalization of leading mRNA biotech companies between March 2023 and September 2026 (in billion U.S.dollars)
Total assets of Adma Biologics from 2021 to 2025 (in million U.S. dollars)
Total assets of Vivos Therapeutics from 2021 to 2025 (in million U.S. dollars)
Total assets of Sanara Medtech from 2021 to 2025 (in million U.S. dollars)
Moderna Inc.
mRNA - Statistics & Facts
mRNA technology
The Top Recipients Of Covid-19 R&D Funding
The World's Untapped Vaccine Potential
How COVID-19 Vaccines Changed Pharma Company Profits
BioNTech - Statistics & Facts
How Many Covid-19 Vaccine Doses Has The U.S. Secured?
Despite Covid, Vaccines Account for Minor Share of Pharma Sales
AstraZeneca - Statistics & Facts
The Countries Funding Covid-19 Vaccine R&D
Coronavirus: the pharma and medtech response
Johnson & Johnson - Statistics & Facts
Biotechnology in pharma worldwide - Statistics & Facts
Companies Fighting COVID-19 Immune to Market Weakness
The Pandemic is Transforming Global Vaccine Production
Coronavirus (COVID-19): vaccines and vaccination campaign
Biotech Value Skyrockets in U.S.
Covid-19 Vaccines: From Zero to 11.2 Billion in a Year

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch